In Opioid MDL, Fears Of Allergan Dissolving To Avoid Payout
A battle has erupted in a bellwether case in multidistrict opioid litigation over access to internal documents at Allergan parent company AbbVie, which is facing insinuations that it might shutter Allergan...To view the full article, register now.
Already a subscriber? Click here to view full article